Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 16773 42 5. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Lewis acid catalysis enables high-purity ornidazole enantiomers with simplified workflow and substantial supply chain cost advantages for global buyers.
Patent CN100338039C details a novel Lewis acid-catalyzed synthesis for S/R-Ornidazole. This method ensures >99.5% purity, offering significant cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.